Frequency Therapeutics Operating Expenses 2011-2026 | FREQ

Annual Operating Expenses Frequency Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
128 M	94.2 M	84.5 M	59 M	98.1 M	64.5 M	49.6 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128 M	49.6 M	82.6 M

Quarterly Operating Expenses Frequency Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
20.3 M	28.7 M	27.6 M	-	23.3 M	24.1 M	21.5 M	-	19.1 M	18.4 M	20.1 M	-	20.3 M	21.3 M	23.3 M	-	25 M	26.9 M	24.8 M	-	16.7 M	14.7 M	12.9 M	-	25.5 M	7.02 M	5.92 M	-	5.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
28.7 M	5.06 M	19.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 9.13	-0.76 %	$ 591 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.91	2.42 %	$ 6.69 M	China
Edesa Biotech EDSA	6.71 M	$ 15.52	-2.39 %	$ 49.6 M	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.47	1.19 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Fortress Biotech FBIO	125 M	$ 2.24	0.9 %	$ 62.5 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.26	0.22 %	$ 144 M	USA
Galapagos NV GLPG	709 M	$ 28.07	0.75 %	$ 2.69 B	Belgium
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	1.64 B	$ 8.2	3.6 %	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	462 M	$ 31.01	-0.13 %	$ 1.78 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
ImmuCell Corporation ICCC	9.8 M	$ 8.44	-	$ 76.2 M	USA
InflaRx N.V. IFRX	52.4 M	$ 1.95	-1.77 %	$ 152 M	Germany
Incyte Corporation INCY	1.62 B	$ 98.87	-0.23 %	$ 19.3 B	USA
InMed Pharmaceuticals INM	9.78 M	$ 0.71	1.28 %	$ 1.74 M	Canada
INmune Bio INMB	47.4 M	$ 1.35	1.5 %	$ 33.4 M	USA
Innoviva INVA	144 M	$ 23.13	0.35 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	512 M	$ 104.54	2.92 %	$ 27.2 B	Germany
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Jaguar Health JAGX	36 M	$ 7.55	-4.13 %	$ 17.6 M	USA
KalVista Pharmaceuticals KALV	161 M	$ 26.67	-0.02 %	$ 1.44 B	Britain
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Innate Pharma S.A. IPHA	63 M	$ 1.43	-4.03 %	$ 235 M	France
Kamada Ltd. KMDA	69 K	$ 8.15	0.49 %	$ 260 M	Israel
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Kazia Therapeutics Limited KZIA	8.82 M	$ 13.24	6.56 %	$ 1.75 B	Australia
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Ligand Pharmaceuticals Incorporated LGND	115 M	$ 223.98	-0.39 %	$ 4.1 B	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 3.22	7.69 %	$ 5.3 M	Israel
Liquidia Corporation LQDA	59.6	$ 38.39	0.62 %	$ 3.3 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aquestive Therapeutics AQST	85.5 M	$ 4.08	0.74 %	$ 436 M	USA